Product: Saxagliptin (Onglyza)
Manufacturer: Bristol-Myers Squibb
(800) 332-2056
www.bms.com
AstraZeneca
(800) 236-9933
www.astrazeneca.com
Reason for label change: The FDA approved a labeling update to Onglyza that reflects the results of further research on the suitability of the drug for people with Type 2 diabetes who also have severe kidney damage or end-stage kidney disease. Drug information for Onglyza now includes a recommended dose that people with serious kidney problems can take safely, but states that these people should have their kidney function tested before starting Onglyza and periodically while taking the drug.
Discontinuations
Product: FreeStyle Navigator
Manufacturer: Abbott Laboratories
(800) 221-7700
www.abbottdiabetescare.com
Reason for discontinuation: Abbott Laboratories has discontinued its FreeStyle Navigator continuous glucose monitor in the United States due not to safety issues with the product, but to problems fulfilling demand for the product and providing replacement parts under warranty. The FreeStyle Navigator will remain in production outside the United States. For its US customers, the company is providing help transitioning to other glucose monitoring options until March 2012. Abbott recommends that people currently using the product call the customer support number (above) for specific information about available options.
